Incomplete coverage of candidate genes: A poorly considered bias

Current Genomics

Volumn 8, Issue 7, 2007, Pages 476-483

  Drago, Antonio ^a   De Ronchi, Diana ^a   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Association studies; Candidate genes; Methodology; Psychiatry genetics

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; CLUSTERIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME P450 1A2; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; DOPAMINE 4 RECEPTOR; DYSBINDIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GHRELIN; LACTOYLGLUTATHIONE LYASE; LITHIUM SALT; MESSENGER RNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MYOSIN LIGHT CHAIN; NEU DIFFERENTIATION FACTOR; NEUROLEPTIC AGENT; RGS4 PROTEIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTOR CLOCK; TRANSCRIPTION FACTOR OTX2; VESICULAR MONOAMINE TRANSPORTER 1;

BIPOLAR DISORDER; DEPRESSION; DRUG RESPONSE; EATING DISORDER; EXON; FEASIBILITY STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE REPLICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DATABASE; GENOME ANALYSIS; HAPLOTYPE; HUMAN; INTRON; MENTAL DISEASE; METHODOLOGY; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE; TATA BOX; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 41749120544     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920207783591681     Document Type: Review

References (85)

1. Licinio, J., Wong, M.L. Pharmacogenomics in psychiatry: genomic considerations. Mol. Psychiatry 2005, 10: 713.
2. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447: 661-78.
3. Cho, H.J., Meira-Lima, I., Cordeiro, Q., Michelon, L., Sham, P., Vallada, H., Collier, D.A. Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol. Psychiatry 2005, 10: 771-81.
4. Sen, S., Burmeister, M., Ghosh, D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am. J. Med. Genet. 2004, 127B: 90-3.
5. Serretti, A., Mandelli, L., Lorenzi, C., Pirovano, A., Olgiati, P., Colombo, C., Smeraldi, E. Serotonin transporter gene influences the time course of improvement of "core" depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders. Psychiatry Res. 2007, 149: 185-93.
6. de Leon, J., Armstrong, S.C., Cozza, K.L. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 2006, 47: 75-85.
7. Haslam, N. Bias in psychopathology research. Curr. Opin. Psychiatry 2006, 19: 625-30.
8. Serretti, A., Kato, M., Kennedy, J.L. Pharmacogenetic studies in depression: a proposal for methodologic guidelines. Pharmacogenomics J. 2007.
9. Shortle, D., Koshland, D., Weinstock, G.M., Botstein, D. Segment-directed mutagenesis: construction in vitro of point mutations limited to a small predetermined region of a circular DNA molecule. Proc. Natl. Acad. Sci. USA 1980, 77: 5375-9.
10. Frazer, K.A., Ballinger, D.G., Cox, D.R., Hinds, D.A., Stuve, L.L., Gibbs, R.A., Belmont, J.W., Boudreau, A., Hardenbol, P., Leal, S.M., Pasternak, S., Wheeler, D.A., Willis, T.D., Yu, F., Yang, H., Zeng, C., Gao, Y., Hu, H., Hu, W., Li, C., Lin, W., Liu, S., Pan, H., Tang, X., Wang, J., Wang, W., Yu, J., Zhang, B., Zhang, Q., Zhao, H., Zhao, H., Zhou, J., Gabriel, S.B., Barry, R., Blumenstiel, B., Camargo, A., Defelice, M., Faggart, M., Goyette, M., Gupta, S., Moore, J., Nguyen, H., Onofrio, R.C., Parkin, M., Roy, J., Stahl, E., Winchester, E., Ziaugra, L., Altshuler, D., Shen, Y., Yao, Z., Huang, W., Chu, X., He, Y., Jin, L., Liu, Y., Shen, Y., Sun, W., Wang, H., Wang, Y., Wang, Y., Xiong, X., Xu, L., Waye, M.M., Tsui, S.K., Xue, H., Wong, J.T., Galver, L.M., Fan, J.B., Gunderson, K., Murray, S.S., Oliphant, A.R., Chee, M.S., Montpetit, A., Chagnon, F., Ferretti, V., Leboeuf, M., Olivier, J.F., Phillips, M.S., Roumy, S., Sallée, C., Verner, A., Hudson, T.J., Kwok, P.Y., Cat, D., Koboldt, D.C., Miller, R.D., Pawlikowska, L., Taillon-Miller, P., Xiao, M., Tsui, L.C., Mak, W., Song, Y.Q., Tam, P.K., Nakamura, Y., Kawaguchi, T., Kitamoto, T., Morizono, T., Nagashima, A., et al. second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449: 851-61.
11. Sullivan, P.F. Spurious genetic associations. Biol. Psychiatry 2007, 61: 1121-6.
12. Fanous, A.H., Neale, M.C., Gardner, C.O., Webb, B.T., Straub, R.E., O'Neill, F.A., Walsh, D., Riley, B.P., Kendler, K.S. Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. Mol. Psychiatry 2007, 12: 958-65.
13. Bulayeva, K.B., Glatt, S.J., Bulayev, O.A., Pavlova, T.A., Tsuang, M.T. Genome-wide linkage scan of schizophrenia: a cross-isolate study. Genomics 2007, 89: 167-77.
14. Vazza, G., Bertolin, C., Scudellaro, E., Vettori, A., Boaretto, F., Rampinelli, S., De Sanctis, G., Perini, G., Peruzzi, P., Mostacciuolo, M.L. Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. Mol. Psychiatry 2007, 12: 87-93.
15. De La Vega, F.M. Selecting single-nucleotide polymorphisms for association studies with SNPbrowser software. Methods Mol. Biol. 2007, 376: 177-93.
16. Horne, B.D., Camp, N.J. Principal component analysis for selection of optimal SNP-sets that capture intragenic genetic variation. Genet. Epidemiol. 2004, 26: 11-21.
17. Schena, M., Heller, R.A., Theriault, T.P., Konrad, K., Lachenmeier, E., Davis, R.W. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol. 1998, 16: 301-6.
18. Halbleib, J.M., Saaf, A.M., Brown, P.O., Nelson, W.J. Transcriptional modulation of genes encoding structural characteristics of differentiating enterocytes during development of a polarized epithelium in vitro. Mol. Biol. Cell 2007, 18: 4261-78.
19. Milanesi, L., Petrillo, M., Sepe, L., Boccia, A., D'Agostino, N., Passamano, M., Di Nardo, S., Tasco, G., Casadio, R., Paolella, G. Systematic analysis of human kinase genes: a large number of genes and alternative splicing events result in functional and structural diversity. BMC Bioinformatics 2005, 6 Suppl 4: S20.
20. Vinogradov, A.E., Anatskaya, O.V. Organismal complexity, cell differentiation and gene expression: human over mouse. Nucleic Acids Res. 2007, 35: 6350-6.
21. Bannister, A.J., Miska, E.A. Regulation of gene expression by transcription factor acetylation. Cell Mol. Life Sci. 2000, 57: 1184-92.
22. Fukuda, Y., Koga, M., Arai, M., Noguchi, E., Ohtsuki, T., Horiuchi, Y., Ishiguro, H., Niizato, K., Iritani, S., Itokawa, M., Arinami, T. Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytes. Biol. Psychiatry 2006, 60: 1331-5.
23. Hoffman, A.R., Hu, J.F. Directing DNA methylation to inhibit gene expression. Cell Mol. Neurobiol. 2006, 26: 425-38.
24. Serman, A., Vlahovic, M., Serman, L., Bulic-Jakus, F. DNA methylation as a regulatory mechanism for gene expression in mammals. Coll. Antropol. 2006, 30: 665-71.
25. Shilatifard, A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 2006, 75: 243-69.
26. Verdone, L., Caserta, M., Di Mauro, E. Role of histone acetylation in the control of gene expression. Biochem. Cell Biol. 2005, 83: 344-53.
27. Clifford, C.P., Nunez, D.J. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet 1996, 347: 1830.
28. Myers, R.L., Airey, D.C., Manier, D.H., Shelton, R.C., Sanders-Bush, E. Polymorphisms in the Regulatory Region of the Human Serotonin 5-HT(2A) Receptor Gene (HTR2A) Influence Gene Expression. Biol. Psychiatry 2006, 11.
29. Serretti, A., Drago, A., De Ronchi, D. HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Curr. Med. Chem. 2007, 14: 2053-69.
30. Hu, X.Z., Rush, A.J., Charney, D., Wilson, A.F., Sorant, A.J., Papanicolaou, G.J., Fava, M., Trivedi, M.H., Wisniewski, S.R., Laje, G., Paddock, S., McMahon, F.J., Manji, H., Lipsky, R.H. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch. Gen. Psychiatry 2007, 64: 783-92.
31. Rogowski, W. Genetic screening by DNA technology: a systematic review of health economic evidence. Int. J. Technol. Assess Health Care 2006, 22: 327-37.
32. Perlis, R.H., Purcell, S., Fava, M., Fagerness, J., Rush, A.J., Trivedi, M.H., Smoller, J.W. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch. Gen. Psychiatry 2007, 64: 689-97.
33. Serretti, A., Mandelli, L., Giegling, I., Schneider, B., Hartmann, A.M., Schnabel, A., Maurer, K., Moller, H.J., Rujescu, D. HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2007, 144: 291-9.
34. Dick, D.M., Plunkett, J., Hamlin, D., Nurnberger, J. Jr., Kuperman, S., Schuckit, M., Hesselbrock, V., Edenberg, H., Bierut, L. Association analyses of the serotonin transporter gene with lifetime depression and alcohol dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Psychiatr. Genet. 2007, 17: 35-8.
35. Serretti, A., Kato, M., De Ronchi, D., Kinoshita, T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol. Psychiatry 2007, 12: 247-57.
36. Kraft, J.B., Peters, E.J., Slager, S.L., Jenkins, G.D., Reinalda, M.S., McGrath, P.J., Hamilton, S.P. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol. Psychiatry 2007, 61: 734-42.
37. Gilbody, S., Lewis, S., Lightfoot, T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am. J. Epidemiol. 2007, 165: 1-13.
38. Li, D., He, L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol. Psychiatry 2007, 12: 47-54.
39. Lin, P.Y. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31: 683-9.
40. Joyce, P.R., McKenzie, J.M., Mulder, R.T., Luty, S.E., Sullivan, P.F., Miller, A.L., Kennedy, M.A. Genetic, developmental and personality correlates of self-mutilation in depressed patients. Aust. N. Z. J. Psychiatry 2006, 40: 225-9.
41. Yu, Y.W., Tsai, S.J., Liou, Y.J., Hong, C.J., Chen, T.J. Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur. Neuropsychopharmacol. 2006, 16: 498-503.
42. Surtees, P.G., Wainwright, N.W., Willis-Owen, S.A., Luben, R., Day, N.E., Flint, J. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol. Psychiatry 2006, 59: 224-9.
43. Lopez de Lara, C., Dumais, A., Rouleau, G., Lesage, A., Dumont, M., Chawky, N., Alda, M., Benkelfat, C., Turecki, G. STin2 variant and family history of suicide as significant predictors of suicide completion in major depression. Biol. Psychiatry 2006, 59: 114-20.
44. Tochigi, M., Hibino, H., Otowa, T., Kato, C., Marui, T., Ohtani, T., Umekage, T., Kato, N., Sasaki, T. Association between dopamine D4 receptor (DRD4) exon III polymorphism and Neuroticism in the Japanese population. Neurosci. Lett. 2006, 398: 333-6.
45. Politi, P., Minoretti, P., Falcone, C., Martinelli, V., Emanuele, E. Association analysis of the functional Ala111 Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci. Lett. 2006, 396: 163-6.
46. Belfer, I., Hipp, H., McKnight, C., Evans, C., Buzas, B., Bollettino, A., Albaugh, B., Virkkunen, M., Yuan, Q., Max, M.B., Goldman, D., Enoch, M.A. Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol. Psychiatry 2006, 11: 301-11.
47. Fanous, A.H., van den Oord, E.J., Riley, B.P., Aggen, S.H., Neale, M.C., O'Neill, F.A., Walsh, D., Kendler, K.S. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am. J. Psychiatry 2005, 162: 1824-32.
48. Schumacher, J., Jamra, R.A., Becker, T., Ohlraun, S., Klopp, N., Binder, E.B., Schulze, T.G., Deschner, M., Schmal, C., Hofels, S., Zobel, A., Illig, T., Propping, P., Holsboer, F., Rietschel, M., Nothen, M.M., Cichon, S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005, 58: 307-14.
49. Serretti, A., Cusin, C., Benedetti, F., Mandelli, L., Pirovano, A., Zanardi, R., Colombo, C., Smeraldi, E. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2005, 137: 36-9.
50. Bondy, B., Baghai, T.C., Zill, P., Schule, C., Eser, D., Deiml, T., Zwanzger, P., Ella, R., Rupprecht, R. Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29: 1094-9.
51. Massat, I., Souery, D., Del-Favero, J., Nothen, M., Blackwood, D., Muir, W., Kaneva, R., Serretti, A., Lorenzi, C., Rietschel, M., Milanova, V., Papadimitriou, G.N., Dikeos, D., Van Broekhoven, C., Mendlewicz, J. Association between COMT (Val(158)Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol. Psychiatry 2005, 10: 598-605.
52. Thomson, P.A., Wray, N.R., Thomson, A.M., Dunbar, D.R., Grassie, M.A., Condie, A., Walker, M.T., Smith, D.J., Pulford, D.J., Muir, W., Blackwood, D.H., Porteous, D.J. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. Mol. Psychiatry 2005, 10: 470-8.
53. Grabe, H.J., Lange, M., Wolff, B., Volzke, H., Lucht, M., Freyberger, H.J., John, U., Cascorbi, I. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol. Psychiatry 2005, 10: 220-4.
54. Kim, S.J., Lee, H.S., Kim, C.H. Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology 2005, 52: 176-82.
55. Zai, G., Arnold, P., Burroughs, E., Barr, C.L., Richter, M.A., Kennedy, J.L. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2005, 134: 25-9.
56. Shimizu, E., Hashimoto, K., Koizumi, H., Kobayashi, K., Itoh, K., Mitsumori, M., Ohgake, S., Okamura, N., Koike, K., Matsuzawa, D., Zhang, L., Kumakiri, C., Nakazato, M., Komatsu, N., Iyo, M. No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29: 708-12.
57. Maron, E., Nikopensius, T., Koks, S., Altmae, S., Heinaste, E., Vabrit, K., Tammekivi, V., Hallast, P., Koido, K., Kurg, A., Metspalu, A., Vasar, E., Vasar, V., Shlik, J. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr. Genet. 2005, 15: 17-24.
58. Lee, Y.J., Hohoff, C., Domschke, K., Sand, P., Kuhlenbaumer, G., Schirmacher, A., Freitag, C.M., Meyer, J., Stober, G., Franke, P., Nothen, M.M., Fritze, J., Fimmers, R., Garritsen, H.S., Stogbauer, F., Decker, J. Norepinephrine transporter (NET) promoter and 5′-UTR polymorphisms: association analysis in panic disorder. Neurosci. Lett. 2005, 377: 40-3.
59. Maron, E., Lang, A., Tasa, G., Liivlaid, L., Toru, I., Must, A., Vasar, V., Shlik, J. Associations between serotonin-related gene polymorphisms and panic disorder. Int. J. Neuropsychopharmacol. 2005, 8: 261-6.
60. Schwab, S.G., Knapp, M., Sklar, P., Eckstein, G.N., Sewekow, C., Borrmann-Hassenbach, M., Albus, M., Becker, T., Hallmayer, J.F., Lerer, B., Maier, W., Wildenauer, D.B. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol. Psychiatry 2006, 11: 837-46.
61. Jeong, S.H., Joo, E.J., Ahn, Y.M., Lee, K.Y., Kim, Y.S. Investigation of genetic association between human Frizzled homolog 3 gene (FZD3) and schizophrenia: results in a Korean population and evidence from meta-analysis. Psychiatry Res. 2006, 143: 1-11.
62. Neves-Pereira, M., Cheung, J.K., Pasdar, A., Zhang, F., Breen, G., Yates, P., Sinclair, M., Crombie, C., Walker, N., St Clair, D.M. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 2005, 10: 208-12.
63. Lachman, H.M., Stopkova, P., Papolos, D.F., Pedrosa, E., Margolis, B., Aghalar, M.R., Saito, T. Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder. Neuropsychobiology 2006, 53: 57-62.
64. Cordeiro, Q., Talkowski, M.E., Chowdari, K.V., Wood, J., Nimgaonkar, V., Vallada, H. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav. 2005, 4: 45-50.
65. Selch, S., Strobel, A., Haderlein, J., Meyer, J., Jacob, C.P., Schmitt, A., Lesch, K.P., Reif, A. MLC1 polymorphisms are specifically associated with periodic catatonia, a subgroup of chronic schizophrenia. Biol. Psychiatry 2007, 61: 1211-4.
66. Chavarria-Siles, I., Walss-Bass, C., Quezada, P., Dassori, A., Contreras, S., Medina, R., Ramirez, M., Armas, R., Salazar, R., Leach, R.J., Raventos, H., Escamilla, M.A. TGFB-induced factor (TGIF): a candidate gene for psychosis on chromosome 18p. Mol. Psychiatry 2007, 12: 1033-41.
67. Pivac, N., Knezevic, J., Kozaric-Kovacic, D., Dezeljin, M., Mustapic, M., Rak, D., Matijevic, T., Pavelic, J., Muck-Seler, D. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder. J. Affect. Disord. 2007, 103: 131-8.
68. Sabunciyan, S., Yolken, R., Ragan, C.M., Potash, J.B., Nimgaonkar, V.L., Dickerson, F., Llenos, I.C., Weis, S. Polymorphisms in the homeobox gene OTX2 may be a risk factor for bipolar disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2007, 144: 1083-6.
69. Nilsson, K.W., Damberg, M., Ohrvik, J., Leppert, J., Lindstrom, L., Anckarsater, H., Oreland, L. Genes encoding for AP-2beta and the Serotonin Transporter are associated with the Personality Character Spiritual Acceptance. Neurosci. Lett. 2007, 411: 233-7.
70. Liou, Y.J., Lai, I.C., Lin, M.W., Bai, Y.M., Lin, C.C., Liao, D.L., Chen, J.Y., Lin, C.Y., Wang, Y.C. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia. Pharmacogenet. Genomics 2006, 16: 151-7.
71. Roberts, J., Scott, A.C., Howard, M.R., Breen, G., Bubb, V.J., Klenova, E., Quinn, J.P. Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat. J. Neurosci. 2007, 27: 2793-801.
72. O'Gara, C., Stapleton, J., Sutherland, G., Guindalini, C., Neale, B., Breen, G., Ball, D. Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment. Pharmacogenet Genomics 2007, 17: 61-7.
73. Tadic, A., Rujescu, D., Muller, M.J., Kohnen, R., Stassen, H.H., Dahmen, N., Szegedi, A. A monoamine oxidase B gene variant and short-term antidepressant treatment response. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31: 1370-7.
74. Ando, T., Ichimaru, Y., Konjiki, F., Shoji, M., Komaki, G. Variations in the preproghrelin gene correlate with higher body mass index, fat mass, and body dissatisfaction in young Japanese women. Am. J. Clin. Nutr. 2007, 86: 25-32.
75. Schlaepfer, I.R., Clegg, H.V., Corley, R.P., Crowley, T.J., Hewitt, J.K., Hopfer, C.J., Krauter, K., Lessem, J., Rhee, S.H., Stallings, M.C., Wehner, J.M., Young, S.E., Ehringer, M.A. The human protein kinase C gamma gene (PRKCG) as a susceptibility locus for behavioral disinhibition. Addict. Biol. 2007, 12: 200-9.
76. Borroni, B., Grassi, M., Costanzi, C., Zanetti, M., Archetti, S., Franzoni, S., Caimi, L., Padovani, A. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease. Neurobiol. Aging 2007, 28: 1231-8.
77. Dannlowski, U., Ohrmann, P., Bauer, J., Kugel, H., Baune, B.T., Hohoff, C., Kersting, A., Arolt, V., Heindel, W., Deckert, J., Suslow, T. Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav. 2006.
78. Gawlik, M., Moller-Ehrlich, K., Mende, M., Jovnerovski, M., Jung, S., Jabs, B., Knapp, M., Stoeber, G. Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traits. BMC Psychiatry 2006, 6: 52.
79. Tiwari, A.K., Deshpande, S.N., Lerer, B., Nimgaonkar, V.L., Thelma, B.K. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism. Pharmacogenomics J. 2006.
80. Lohoff, F.W., Dahl, J.P., Ferraro, T.N., Arnold, S.E., Gallinat, J., Sander, T., Berrettini, W.H. Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder. Neuropsychopharmacology 2006, 31: 2739-47.
81. Lachman, H.M., Pedrosa, E., Nolan, K.A., Glass, M., Ye, K., Saito, T. Analysis of polymorphisms in AT-rich domains of neuregulin 1 gene in schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2006, 141: 102-9.
82. Xu, C., Macciardi, F., Li, P.P., Yoon, I.S., Cooke, R.G., Hughes, B., Parikh, S.V., McIntyre, R.S., Kennedy, J.L., Warsh, J.J. Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2006, 141: 36-43.
83. Zaboli, G., Gizatullin, R., Nilsonne, A., Wilczek, A., Jonsson, E.G., Ahnemark, E., Asberg, M., Leopardi, R. Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology 2006, 31: 1982-90.
84. Viana, M.M., De Marco, L.A., Boson, W.L., Romano-Silva, M.A., Correa, H. Investigation of A218C tryptophan hydroxylase polymorphism: association with familial suicide behavior and proband's suicide attempt characteristics. Genes Brain Behav. 2006, 5: 340-5.
85. Yamada, K., Hattori, E., Iwayama, Y., Ohnishi, T., Ohba, H., Toyota, T., Takao, H., Minabe, Y., Nakatani, N., Higuchi, T., Detera-Wadleigh, S.D., Yoshikawa, T. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol. Psychiatry 2006, 60: 192-201.